Quantum computing is moving from theoretical promise to practical reality in healthcare, with the global market projected to grow from $200 million in 2024 to billions by 2034. Major breakthroughs in 2025, including Google’s quantum computer achieving 13,000 times the speed of classical supercomputers, are enabling revolutionary applications across drug discovery, medical imaging, personalized medicine, and clinical trials.
Twenty-five years after scientists completed the Human Genome Project (a biological moonshot that took 13 years and cost $2.7 billion) the same task can now be accomplished in under 12 minutes for a few hundred dollars.
Yet even today’s most powerful computers struggle with certain genomic challenges that stretch beyond their capabilities. Enter quantum computing: a technology once confined to theoretical physics laboratories that is now beginning to solve real-world medical problems.
As 2026 unfolds, quantum computing is transitioning from laboratory curiosity to practical tool, with profound implications for how we diagnose disease, discover drugs, and deliver personalized medicine. The global quantum computing in healthcare market, valued at approximately $200 million in 2024, is projected to grow at a compound annual growth rate of 38 to 42 percent through 2034, reflecting an industry preparing for computational transformation.
Beyond Classical Computing Limits
Unlike classical computers that process information as binary bits (ones and zeroes) quantum computers harness the bizarre properties of quantum mechanics.
They utilize qubits, which can exist in superposition, embodying both states simultaneously, and entanglement, where quantum states become intrinsically linked regardless of distance. This fundamental difference allows quantum systems to explore multiple solutions simultaneously rather than sequentially.
In October 2025, Google announced they achieved a verifiable test where their quantum computer was 13,000 times faster than the world’s fastest classical supercomputer.
It was the first time in history this milestone was reached. IonQ separately claimed to have surpassed classical methods in chemistry simulations and achieved quantum advantage in drug discovery applications.
“The advance I’ve been most excited about is not really in the quantum stuff at all,” noted Eli Levenson-Falk, Associate Professor at USC. “It’s in all the supporting technologies. Today, researchers can buy tools like quantum controllers off the shelf, allowing them to focus more on science than setup.”
Drug Discovery
The pharmaceutical industry faces a daunting challenge: developing a new drug costs approximately one to three billion dollars and takes around ten years, with only a ten percent success rate. Quantum computing promises to revolutionize this process by enabling unprecedented molecular simulations.
“This is the first time quantum computing has been successfully used for a drug discovery project that includes experimental validation,” said Christoph Gorgulla, PhD, at St. Jude Children’s Research Hospital and the University of Toronto. Their team successfully targeted the KRAS protein (one of the most mutated genes in cancers, often called “undruggable”) by combining classical and quantum machine learning models to generate novel drug candidates.
The Moderna-IBM partnership exemplifies this quantum-AI synergy. “We can do great things today without a quantum computer to attack that,” explains Wade Davis, Vice President of Computational Science at Moderna. “But there is the potential (because of the nature of quantum) to do some things in a different way for those type of problems.” The collaboration focuses on predicting how messenger RNA molecules fold, which is critical information when designing RNA-based drugs.
Pasqal’s work with Qubit Pharmaceuticals demonstrates quantum computing’s practical applications. By utilizing quantum principles such as superposition and entanglement, quantum methods evaluate numerous molecular configurations far more efficiently than classical systems, successfully implementing algorithms on neutral-atom quantum computers for molecular biology tasks.
McKinsey estimates quantum computing could create $200 billion to $500 billion in value for the life sciences industry by 2035, driven primarily by its ability to perform first-principles calculations based on fundamental quantum physics laws.
Medical Imaging and Diagnostics: Seeing What Was Previously Invisible
Quantum computing is transforming how clinicians detect and diagnose disease through enhanced medical imaging and pattern recognition. Quantum machine learning leverages quantum algorithms to process and analyze large, complex datasets more efficiently than classical systems, with applications in diagnostic analytics where quantum-enhanced models can detect patterns in radiological images with greater speed and precision.
Recent studies demonstrate quantum computing’s potential to enhance diagnostic accuracy, enabling earlier detection of diseases such as Alzheimer’s, cancer, and osteoarthritis, supporting more timely interventions and better prognoses.
Research at the Fraunhofer Institute for Cognitive Systems is exploring quantum convolutional neural networks (QCNNs) for brain tumor screening. The quantum convolutional layer performs significantly more efficient and compact calculations than standard convolutional layers, potentially requiring less training data and fewer iterations to achieve the same quality as conventional CNNs.
Quantum computing has enhanced precision in radiation therapy dose distribution calculations, showing a 25 percent improvement in accuracy, ensuring tumors receive maximum radiation doses while minimizing harm to surrounding tissues.
The World Economic Forum illustrates quantum’s diagnostic potential with a compelling scenario: A cardiac patient arrives at emergency with chest pain. Within minutes, a quantum magnetocardiography sensor detects subtle electrical anomalies that traditional electrocardiograms cannot capture, flagging a life-threatening condition before irreversible damage occurs.
Tailoring Treatment to Individual Patients
Perhaps nowhere is quantum computing’s promise more profound than in personalized medicine, where treatments are tailored to individual genetic profiles and biological characteristics. Quantum computing leverages superposition and entanglement to offer a fundamentally new paradigm for accelerating molecular simulations, biomarker discovery, and high-dimensional data analysis in precision medicine.
A full human genome contains 3 billion base pairs, generating hundreds of gigabytes of raw data per individual. When proteomic and metabolomic data are layered on top, datasets quickly reach petabyte scales, overwhelming traditional computing systems. Quantum systems can process these massive, multi-dimensional datasets exponentially faster.
Quantum-enhanced machine learning can process high-dimensional, multi-omics datasets (genomic, transcriptomic, proteomic, and metabolomic profiles) faster and more accurately than classical systems, helping design personalized therapeutic strategies in oncology, neurology, and rare genetic disorders.
The Wellcome Sanger Institute’s partnership with Quantinuum exemplifies this frontier. “The overall goal is to perform a range of genomic processing tasks for the most complex and variable genomes and sequences, a task that can go beyond the capabilities of current classical computers,” states the Sanger Institute. Their collaboration uses Quantinuum’s System H2 quantum computer, which holds the global record for Quantum Volume at over 8 million.
Quantum algorithms can integrate diverse data sources (a patient’s genome, medical history, and lifestyle factors) to provide treatment recommendations tailored to each individual, potentially revolutionizing how treatments are personalized based on genetic profiles.
Optimizing Complex Clinical Systems
Beyond scientific discovery, quantum computing promises to transform healthcare delivery itself. Quantum algorithms can optimize complex variables such as patient selection, treatment sequencing, and adaptive randomization in clinical trials, resulting in safer, more effective treatments and faster trial completion.
“Optimization problems are really something that we can do today,” said Herman Van Vlijmen, Head of Computer-Aided Drug Design at Johnson & Johnson, which collaborates with Pasqal. These optimization algorithms help determine how well drugs interact with intended targets, program clinical trials more efficiently, and manage supply chains.
In broader healthcare operations, quantum systems enable intelligent resource allocation, helping hospitals optimize bed usage, staff deployment, and equipment availability in real-time, reducing treatment delays and streamlining workflows.
Why Healthcare Leaders Must Act Now
Major industry events signal quantum computing’s arrival as a strategic priority. At CES 2026, the launch of CES Foundry as a dedicated venue for AI, blockchain, and quantum technologies signals a structural shift, with “Quantum Leap: Computing’s Next Frontier in Health” placed directly within the Digital Health Summit. Similarly, the JP Morgan Healthcare Conference 2026 features “Why Does Biopharma Need Quantum Now?” framing quantum computing as a timely strategic consideration rather than a distant bet.
Quantum computing companies raised $3.77 billion in equity funding during the first nine months of 2025 (nearly triple the $1.3 billion raised in all of 2024) with national governments investing $10 billion by April 2025, up from $1.8 billion in all of 2024.
The AI-in-healthcare market is projected to reach $491 billion by 2032, growing at 43 percent annually, with quantum computing positioned to unlock AI’s next frontier by solving problems classical systems cannot reach.
Ryan Babbush, who leads quantum algorithms research at Google, offers cautious optimism: “There is reason to remain cautiously optimistic about the power of quantum computing for machine learning,” particularly for drug design efforts to develop molecules that achieve desired functions.
Real-World Implementations
Several pioneering collaborations demonstrate quantum computing’s practical applications. Cleveland Clinic and IBM operate the world’s first quantum computer dedicated to healthcare research, installed at Cleveland Clinic’s main campus. AstraZeneca, Amazon Web Services, IonQ, and NVIDIA demonstrated a quantum-accelerated computational chemistry workflow for small-molecule drug synthesis.
Boehringer Ingelheim and PsiQuantum are exploring enhanced electronic structure simulations for drug development. Merck KGaA and Amgen collaborate with QuEra to leverage quantum computing for predicting biological activity of drug candidates.
Emile Hoskinson of D-Wave described using their quantum systems to simulate the behavior of a magnetic material (a task too complex for classical computers) realizing a vision first proposed by physicist Richard Feynman in 1981: using quantum systems to simulate the quantum world.
Challenges
Despite remarkable progress, significant hurdles remain. Current quantum implementations remain limited compared to classical computing in many practical applications, and they have yet to demonstrate a practical advantage over classical methods in processing large, complex datasets for real-world machine learning tasks.
Error rates, scalability, hardware limitations, and integration within clinical environments pose ongoing challenges. For genomics specifically, the expected quantum speedup may vanish under realistic assumptions, with quantum computing potentially offering advantages only for a specific subset of particularly challenging tasks requiring relatively limited variables.
However, the consensus among researchers is clear: these are engineering challenges, not fundamental limitations. As quantum hardware improves and error correction advances, practical applications will expand rapidly.
Preparing for Quantum’s Clinical Integration
For healthcare organizations, the strategic imperative is clear. “Quantum computing is not about replacing classical systems. It’s about enhancing specific bottlenecks in diagnostics like multi-omics analysis, imaging interpretation, and molecular simulation. The strategic decisions made in the next 18 to 24 months will determine whether your organization is a spectator or a key competitor in this new era.”
The World Economic Forum’s white paper on quantum technologies in healthcare outlines four value pillars: drug discovery and development, advanced diagnostics, secure health data, and healthcare system optimization. AI operates on an immediate horizon, delivering measurable gains today, while quantum operates on a transformational horizon, requiring investment now to unlock breakthroughs that could redefine how we detect, treat and understand disease.
The Quantum Future of Medicine
As 2026 progresses, quantum computing is no longer theoretical. It’s becoming economical and practical. The convergence of quantum computing with artificial intelligence, improved hardware reliability, and growing institutional expertise is creating unprecedented opportunities to address healthcare’s most intractable challenges.
From accelerating drug discovery timelines from years to months, to enabling truly personalized medicine based on quantum-level biological understanding, to detecting diseases before symptoms appear, quantum computing represents a fundamental shift in what’s computationally possible in medicine.
This partnership between quantum technology and healthcare means we may soon reach an important step forward in human health research, one that could change medicine and computational biology as dramatically as the original Human Genome Project did a quarter-century ago.
The question for healthcare leaders is no longer whether quantum will reshape medicine. It’s whether their organizations will be ready to participate in and benefit from that transformation.
Get the latest news and insights that are shaping the world. Subscribe to Impact Newswire to stay informed and be part of the global conversation.
Got a story to share? Pitch it to us at info@impactnews-wire.com and reach the right audience worldwide
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.
